MedMira Inc (MMIRF)
0.06
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
MedMira Total Assets (Quarterly): 3.331M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 3.331M |
| October 31, 2023 | 3.316M |
| July 31, 2023 | 2.755M |
| April 30, 2023 | 2.803M |
| January 31, 2023 | 2.782M |
| October 31, 2022 | 2.775M |
| July 31, 2022 | 2.954M |
| April 30, 2022 | 3.166M |
| January 31, 2022 | 3.568M |
| October 31, 2021 | 3.928M |
| July 31, 2021 | 3.118M |
| April 30, 2021 | 2.996M |
| January 31, 2021 | 3.128M |
| October 31, 2020 | 3.423M |
| July 31, 2020 | 2.531M |
| April 30, 2020 | 2.214M |
| January 31, 2020 | 2.143M |
| October 31, 2019 | 2.024M |
| July 31, 2019 | 0.192M |
| April 30, 2019 | 0.2046M |
| January 31, 2019 | 0.2463M |
| October 31, 2018 | 0.2206M |
| July 31, 2018 | 0.2309M |
| April 30, 2018 | 0.216M |
| January 31, 2018 | 0.2821M |
| Date | Value |
|---|---|
| October 31, 2017 | 0.4827M |
| July 31, 2017 | 0.5405M |
| April 30, 2017 | 0.5124M |
| January 31, 2017 | 0.6229M |
| October 31, 2016 | 0.6435M |
| July 31, 2016 | 0.6614M |
| April 30, 2016 | 1.710M |
| January 31, 2016 | 2.771M |
| October 31, 2015 | 3.587M |
| July 31, 2015 | 1.371M |
| April 30, 2015 | 1.066M |
| January 31, 2015 | 0.9818M |
| October 31, 2014 | 1.507M |
| July 31, 2014 | 1.688M |
| April 30, 2014 | 1.628M |
| January 31, 2014 | 3.221M |
| October 31, 2013 | 5.465M |
| July 31, 2013 | 1.132M |
| April 30, 2013 | 0.8483M |
| January 31, 2013 | 1.270M |
| October 31, 2012 | 2.200M |
| July 31, 2012 | 2.965M |
| April 30, 2012 | 0.6023M |
| January 31, 2012 | 0.5902M |
| October 31, 2011 | 0.521M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.192M
Minimum
Jul 2019
3.928M
Maximum
Oct 2021
2.797M
Average
2.954M
Median
Jul 2022
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.33M |
| Shareholders Equity (Quarterly) | -12.00M |
| Debt to Equity Ratio | -0.435 |
| Current Ratio | 0.146 |
| Net Debt Paydown Yield | -0.36% |